-
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims
Mar 10, 2025, 14:00 PM -
Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies
Mar 10, 2025, 14:00 PM -
Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia
Mar 10, 2025, 14:00 PM -
Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States
Mar 10, 2025, 14:00 PM -
Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline
Mar 10, 2025, 14:00 PM -
Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences
Mar 10, 2025, 14:00 PM -
Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements
Mar 10, 2025, 14:00 PM -
From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU
Mar 10, 2025, 14:00 PM -
Utilizing Machine Learning to Predict Survival Outcomes in Multiple Myeloma Patients with Diabetes: Insights from a 20-Year Cohort Study
Mar 10, 2025, 14:00 PM -
Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence
Mar 10, 2025, 14:00 PM -
Targeted Review and Gap Assessment for Refractory Metastatic Colorectal Cancer Without Liver Metastases
Mar 10, 2025, 14:00 PM -
Pharmacometric-Pharmacoeconomic Modeling and Simulation to Assess Target Product Profile Characteristics in Early Drug Development: Application to Atopic Dermatitis
Mar 10, 2025, 14:00 PM -
A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review
Mar 10, 2025, 14:00 PM -
Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective
Mar 10, 2025, 14:00 PM -
Hope as a Catalyst: AI-Based Conversational Agents in Mental Health Support
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Patients with Itch-Dominant Moderate-to-Severe Atopic Dermatitis Treated in Private Dermatology Facilities in the United States
Mar 10, 2025, 14:00 PM -
Evaluation of Marginal Healthcare Expenditures and Health-related Quality of Life in Multiple Sclerosis with a Bayesian Quantile Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling
Mar 10, 2025, 14:00 PM
